Genvor was founded by Jesse Jaynes, Clayton Yates.

How much funding has Genvor raised?

Genvor has disclosed $425K raised across 1 of its 2 known rounds.

Where is Genvor headquartered?

Genvor is headquartered in Henderson, US.

Genvor

OTC: GNVR

Henderson, US · Nevada corporation

Find your way into Genvor

28 people in our graph share verified history with the Genvor team — schools, employers, funds. One of them is your warm intro.

Assa Camaraunlockedknows Chad Pawlak · together at Johnson & Wales University

×9knows the team · via Johnson & Wales University

×2knows the team · via Jack Welch Management Institute

Genvor develops and commercializes AI-accelerated peptide technology designed to address agricultural challenges including crop protection against pathogens and pests, yield enhancement, and nutrient optimization. The company operates through a partnership-driven licensing model with agricultural organizations and leverages its proprietary BioCypher Algorithm to discover engineered peptides for sustainable crop protection, animal health applications, and environmental stress tolerance.

AgTech

Founders & leadership

Jesse JaynesinCo-founder

Clayton YatesCo-founder

Chad Pawlak inExecutiveChad Pawlak has over 25 years of executive experience building and scaling businesses across technology, agriculture, biotechnology, and regulated industries, with prior roles spanning CEO, Chief Revenue Officer, and Chief Commercial Officer, and serves as Executive Officer and Director at Genvor.

Reported raises · per SEC filings

Form D private placements

$425K disclosed across 1 of 2 rounds · 2025

▶$7MofferedDec 2025 · Agriculture

Rule 506(c)

Officers, directors & promoters on the filing

Chad PawlakExecutive Officer, Director
Clayton YatesDirector
Jesse JaynesExecutive Officer, Director

Offering amount: $7M
Minimum investment: $10K
Proceeds to insiders: $500K
Incorporated: Corporation, Nevada
Federal exemptions: 06c

Full filing on SEC EDGAR ↗

▶$425KraisedJun 2025 · 6 investors · Agriculture

Rule 506(b)

Officers, directors & promoters on the filing

Jesse JaynesExecutive Officer, Director
Chad PawlakExecutive Officer, Director
Clayton YatesExecutive Officer, Director

Offering amount: $2.5M
Amount sold: $425K
Minimum investment: $10K
Proceeds to insiders: $300K
First sale: Apr 2025
Incorporated: Corporation, Nevada
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events

$420Kvaluation at IPOMay 2020 · $0.02/share · S-1/A

filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

In the news

Genvor Incorporated announced that it expects to receive $7 million in funding | MarketScreenermarketscreener.com · Dec 2025

Form 10-K/A Genvor Inc For: Sep 30streetinsider.com · Jan 2024

Frequently asked questions

What does Genvor do?: Genvor develops and commercializes AI-accelerated peptide technology designed to address agricultural challenges including crop protection against pathogens and pests, yield enhancement, and nutrient optimization. The company operates through a partnership-driven licensing model with agricultural organizations and leverages its proprietary BioCypher Algorithm to discover engineered peptides for sustainable crop protection, animal health applications, and environmental stress tolerance.
Who founded Genvor?: Genvor was founded by Jesse Jaynes, Clayton Yates.
How much funding has Genvor raised?: Genvor has disclosed $425K raised across 1 of its 2 known rounds.
Where is Genvor headquartered?: Genvor is headquartered in Henderson, US.